Stocks/TSX-V/ZCT

Zero Candida Technologies Inc. (ZCT : TSX-V)

Common Stock

$0.15

CAD

-0.03 (-16.67%)

Last updated: 2026-07-20

ZCT

Zero Candida Technologies Inc.

Source:WealthAwesomeWealthAwesome
$0.02 (-14.29%)
30 day period
$0.14$0.17$0.20Feb 13May 4Jul 20

Performance

1 Day

-16.67%

1 Week

-3.23%

1 Month

-14.29%

YTD

-21.05%

Key Statistics

Market Cap

$3.52M

52W High

$0.28

52W Low

$0.11

P/E Ratio

-

50 Day MA

$0.17

200 Day MA

$0.20

Beta

-

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/20/2026$0.15$0.15$0.15$0.15$0.15500
7/17/2026$0.18$0.18$0.18$0.18$0.18700
6/30/2026$0.15$0.15$0.15$0.15$0.157,500
6/26/2026$0.17$0.17$0.15$0.15$0.152,385
6/25/2026$0.14$0.15$0.14$0.15$0.1520,000
6/23/2026$0.15$0.15$0.14$0.14$0.141,000
6/8/2026$0.17$0.17$0.17$0.17$0.1717,000
6/3/2026$0.16$0.17$0.16$0.17$0.171,000
5/29/2026$0.19$0.20$0.17$0.20$0.201,500
5/27/2026$0.19$0.19$0.19$0.19$0.191,500

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ZCT's historical volatility

HistoricalForecast68%95%
C$0.01C$0.28C$0.56C$0.83C$1.10C$1.37TodayFeb 11Nov 27Jul 20Sep 1Oct 15Nov 27

30-Day Vol

197.6%

Annualized

90-Day Vol

157.4%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.13

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.14C$0.07C$0.28
60 trading daysC$0.13C$0.05C$0.35
90 trading daysC$0.13C$0.04C$0.41

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Zero Candida Technologies Inc.

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

Financials

Revenue (TTM)
$0
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
-0.05
Book Value
-

Advertisement

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About ZCT

Advertisement